Aug 14, 2025 4:10 pm EDT VolitionRx Limited Announces Second Quarter 2025 Financial Results and Business Update
Aug 8, 2025 8:30 am EDT VolitionRx Limited Schedules Second Quarter 2025 Earnings Conference Call and Business Update
Jul 8, 2025 8:00 am EDT Volition Announces Groundbreaking Lateral Flow Test for Point-of-Care Quantification of Nucleosomes
Jun 12, 2025 8:30 am EDT Volition Announces MARS Consortium Clinical Study Suggests Nu.Q® H3.1. Concentrations are Closely Associated with Sepsis and Organ Failure
Jun 4, 2025 9:00 pm EDT Volition Announces Two Oral Presentations at Asian Meeting of Animal Medicine Specialties
May 15, 2025 5:37 pm EDT VolitionRx Limited Announces First Quarter 2025 Financial Results and Business Update
